Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Martinelli, G
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy. [electronic resource] - Bone marrow transplantation Apr 2000 - 729-36 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0268-3369
10.1038/sj.bmt.1702207 doi
Adolescent
Adult
Antineoplastic Agents--therapeutic use
Bone Marrow Cells--pathology
Bone Marrow Transplantation
Combined Modality Therapy
Cytarabine--therapeutic use
Disease-Free Survival
Female
Follow-Up Studies
Fusion Proteins, bcr-abl--genetics
Genes, abl
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Karyotyping
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Middle Aged
Recombinant Proteins
Remission Induction
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Transcription, Genetic
Transplantation, Autologous
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy. [electronic resource] - Bone marrow transplantation Apr 2000 - 729-36 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0268-3369
10.1038/sj.bmt.1702207 doi
Adolescent
Adult
Antineoplastic Agents--therapeutic use
Bone Marrow Cells--pathology
Bone Marrow Transplantation
Combined Modality Therapy
Cytarabine--therapeutic use
Disease-Free Survival
Female
Follow-Up Studies
Fusion Proteins, bcr-abl--genetics
Genes, abl
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Karyotyping
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Middle Aged
Recombinant Proteins
Remission Induction
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Transcription, Genetic
Transplantation, Autologous